Comprehensive Analysis of TICRR in Hepatocellular Carcinoma Based on Bioinformatics Analysis

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2023 Jun 2

PMID 37266876

Authors

Jing-Jing Chen

Lu-Lu Zhang

Zhen Liu

Wan Qi Men

Fang Chen

Jilu Shen

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the leading cause of cancer-associated death in the world. However, due to the complexity of HCC, it is urgent for us to find a reliable and accurate biomarker for HCC gene therapy.TopBP1-interacting checkpoint and replication regulator (TICRR), known as Treslin in vertebrate and sld3 in yeast, is involved in the tumorigenesis, progression, matastasis, diagnosis, and predicting prognosis of HCC. Disappointingly, the mechanism of TICRR expression in HCC is still not described in detail and requires further analysis. In this study, TCGA ( www.tcga-data.nci.nih.gov/tcga/ ) datasets and GEO ( www.ncbi.nlm.nih.gov/geo ) datasets were used to analyze the expression of TICRR in HCC, the relevance of TICRR mRNA expression and clinicopathological characteristics in patients with HCC, and the relationship between TICRR expression and immune infiltration level in Patients with HCC. Based on MethSurv database, the impact of TICRR in patients with HCC was investigated. In addition, GO/KEGG enrichment analysis of TICRR co-expression was performed using the R package. TICRR was found drastically highly expressed in a variety of cancer types including HCC.ROC curve analysis showed that TICRR had higher accuracy in predicting HCC compared with AFP. The expression level of TICRR was marked positively correlated with tumor stage and prognosis in Patients with HCC.GO/KEGG enrichment analysis showed that TICRR was associated with cell division and cell cycle as well as p53 signaling pathway. In addition, patients with high TICRR methylation of cg05841809, cg09403165, and cg03312532 CpG sites were significantly correlated with poor prognosis of HCC. This study demonstrated that increased TICRR expression in HCC might play an important role in the tumorigenesis, progression, diagnosis, and predicting prognosis of HCC. Therefore, TICRR might be used as a promising diagnostic and prognostic biomarker for HCC gene therapy.

Citing Articles

The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.

Ojewunmi O, Adeyemo T, Oyetunji A, Inyang B, Akinrindoye A, Mkumbe B Hum Mol Genet. 2024; 33(10):919-929.

PMID: 38339995 PMC: 11070134. DOI: 10.1093/hmg/ddae014.

References

Chalasani N, Ramasubramanian T, Bhattacharya A, Olson M, Edwards V D, Roberts L . A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020; 19(12):2597-2605.e4. DOI: 10.1016/j.cgh.2020.08.065. View

Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N . Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020; 10(9):2993-3036. PMC: 7539784. View

Dalwadi D, Torrens L, Abril-Fornaguera J, Pinyol R, Willoughby C, Posey J . Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Mol Ther. 2021; 29(2):680-690. PMC: 7854305. DOI: 10.1016/j.ymthe.2020.10.018. View

Dhiman N, Shagaghi N, Bhave M, Sumer H, Kingshott P, Rath S . Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model. Cytotherapy. 2020; 23(1):25-36. DOI: 10.1016/j.jcyt.2020.07.004. View

Ding Y, Liu K, Xu Y, Zhao Q, Lou S, Xiang X . Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Med. 2020; 9(9):3057-3069. PMC: 7196063. DOI: 10.1002/cam4.2968. View

Horie M, Kaczkowski B, Ohshima M, Matsuzaki H, Noguchi S, Mikami Y . Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC. Mol Cancer Res. 2017; 15(10):1354-1365. DOI: 10.1158/1541-7786.MCR-17-0191. View

Petersson A, Andersson N, Hau S, Eberhard J, Karlsson J, Chattopadhyay S . Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. Mol Cancer Res. 2022; 20(5):749-761. PMC: 9381114. DOI: 10.1158/1541-7786.MCR-21-0986. View

Sun X, Yi J, Yang J, Han Y, Qian X, Liu Y . An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance. Theranostics. 2021; 11(11):5346-5364. PMC: 8039961. DOI: 10.7150/thno.58385. View

Tekpli X, Skaug V, Baera R, Phillips D, Haugen A, Mollerup S . Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report. Cell Oncol (Dordr). 2016; 39(6):583-589. DOI: 10.1007/s13402-016-0295-3. View

10.

Wang J, He H, Jiang Q, Wang Y, Jia S . Promotes HCC Metastasis Via Transcription Factors Snail/Zeb1-Mediated EMT Mechanism. Onco Targets Ther. 2020; 13:12489-12500. PMC: 7727033. DOI: 10.2147/OTT.S257363. View

11.

Wang Y, Zhou C, Luo H, Cao J, Ma C, Cheng L . Prognostic implications of immune-related eight-gene signature in pediatric brain tumors. Braz J Med Biol Res. 2021; 54(7):e10612. PMC: 8130135. DOI: 10.1590/1414-431X2020e10612. View

12.

Wittig K, Sansam C, Noble T, Goins D, Sansam C . The CRL4DTL E3 ligase induces degradation of the DNA replication initiation factor TICRR/TRESLIN specifically during S phase. Nucleic Acids Res. 2021; 49(18):10507-10523. PMC: 8501952. DOI: 10.1093/nar/gkab805. View

13.

Yang L, Cui Y, Sun X, Wang Y . Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis. Aging (Albany NY). 2021; 13(3):4564-4589. PMC: 7906164. DOI: 10.18632/aging.202417. View

14.

Yuan G, Zhou Y, Liu J, Hu C, Huang H, Ren Y . AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFP. Int J Clin Exp Pathol. 2020; 12(4):1315-1323. PMC: 6947068. View

15.

Zhang Y, Xu H, Mu J, Guo S, Ye L, Li D . Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression. J Cell Physiol. 2018; 234(5):6965-6975. DOI: 10.1002/jcp.27439. View

16.

Zhang G, Zhang G . Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett. 2019; 17(4):3944-3951. PMC: 6425392. DOI: 10.3892/ol.2019.10049. View

17.

Zheng G, Zhang Y, Wang H, Ding E, Qu A, Su P . Genome-wide DNA methylation analysis by MethylRad and the transcriptome profiles reveal the potential cancer-related lncRNAs in colon cancer. Cancer Med. 2020; 9(20):7601-7612. PMC: 7571838. DOI: 10.1002/cam4.3412. View

18.

Zhu W, Peng Y, Wang L, Hong Y, Jiang X, Li Q . Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy. Hepatology. 2018; 68(2):574-589. PMC: 7368991. DOI: 10.1002/hep.29844. View

19.

Zhu Y, Lu H, Zhang D, Li M, Sun X, Wan L . Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clin Epigenetics. 2018; 10:30. PMC: 5833094. DOI: 10.1186/s13148-018-0458-3. View